X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE TORRENT PHARMA TTK HEALTHCARE/
TORRENT PHARMA
 
P/E (TTM) x 22.0 44.3 49.7% View Chart
P/BV x 7.4 6.3 118.2% View Chart
Dividend Yield % 0.4 0.8 47.9%  

Financials

 TTK HEALTHCARE   TORRENT PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
TORRENT PHARMA
Mar-18
TTK HEALTHCARE/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs6631,550 42.8%   
Low Rs3991,144 34.9%   
Sales per share (Unadj.) Rs535.6354.7 151.0%  
Earnings per share (Unadj.) Rs15.940.1 39.8%  
Cash flow per share (Unadj.) Rs20.064.2 31.2%  
Dividends per share (Unadj.) Rs4.0014.00 28.6%  
Dividend yield (eoy) %0.81.0 72.4%  
Book value per share (Unadj.) Rs137.6273.1 50.4%  
Shares outstanding (eoy) m7.77169.22 4.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.8 26.1%   
Avg P/E ratio x33.333.6 99.1%  
P/CF ratio (eoy) x26.521.0 126.5%  
Price / Book Value ratio x3.94.9 78.3%  
Dividend payout %25.134.9 71.8%   
Avg Mkt Cap Rs m4,127227,897 1.8%   
No. of employees `0001.714.7 11.6%   
Total wages/salary Rs m60711,353 5.3%   
Avg. sales/employee Rs Th2,436.74,083.0 59.7%   
Avg. wages/employee Rs Th355.2772.3 46.0%   
Avg. net profit/employee Rs Th72.5461.3 15.7%   
INCOME DATA
Net Sales Rs m4,16260,021 6.9%  
Other income Rs m612,988 2.0%   
Total revenues Rs m4,22363,009 6.7%   
Gross profit Rs m19713,493 1.5%  
Depreciation Rs m324,086 0.8%   
Interest Rs m303,085 1.0%   
Profit before tax Rs m1979,310 2.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m732,529 2.9%   
Profit after tax Rs m1246,781 1.8%  
Gross profit margin %4.722.5 21.1%  
Effective tax rate %37.027.2 136.3%   
Net profit margin %3.011.3 26.3%  
BALANCE SHEET DATA
Current assets Rs m1,62952,623 3.1%   
Current liabilities Rs m1,05852,022 2.0%   
Net working cap to sales %13.71.0 1,368.8%  
Current ratio x1.51.0 152.2%  
Inventory Days Days30120 24.9%  
Debtors Days Days3476 44.1%  
Net fixed assets Rs m55685,016 0.7%   
Share capital Rs m78846 9.2%   
"Free" reserves Rs m87845,376 1.9%   
Net worth Rs m1,06946,222 2.3%   
Long term debt Rs m15941,115 0.4%   
Total assets Rs m2,399142,432 1.7%  
Interest coverage x7.64.0 188.6%   
Debt to equity ratio x0.10.9 16.7%  
Sales to assets ratio x1.70.4 411.6%   
Return on assets %6.46.9 92.5%  
Return on equity %11.614.7 79.0%  
Return on capital %18.514.2 130.0%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m3314,580 0.2%   
Fx outflow Rs m633,600 1.8%   
Net fx Rs m-3010,980 -0.3%   
CASH FLOW
From Operations Rs m1278,942 1.4%  
From Investments Rs m-146-47,070 0.3%  
From Financial Activity Rs m2234,174 0.1%  
Net Cashflow Rs m3-3,655 -0.1%  

Share Holding

Indian Promoters % 65.4 71.5 91.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 7.0 52.7%  
FIIs % 5.2 12.6 41.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 8.8 293.2%  
Shareholders   12,723 26,511 48.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  ELDER PHARMA  NOVARTIS  PANACEA BIOTECH  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Marginally Lower; FMCG & IT Stocks Witness Losses(Closing)

After opening the day on a positive note today, Indian share markets witnessed losses thereafter and ended their trading session marginally lower.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 13.3% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 13.3% YoY). Sales on the other hand came in at Rs 19 bn (up 36.2% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Oh Yes! This is the Best Trading Opportunity in Two Decades(Profit Hunter)

Sep 21, 2018

Getting ready to buy stocks once this correction is over? This private sector bank should be on a profit hunter's radar.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

How IL&FS Rating Downgrade Will Impact Your Mutual Funds...(Outside View)

Sep 17, 2018

PersonalFN explains the impact of IL&FS rating downgrade on mutual funds.

How To Identify Sachin Tendulkars And Rahul Dravids Of Tomorrow For Your Mutual Fund Portfolio(Outside View)

Sep 19, 2018

PersonalFN explains how to pick 'undiscovered' or lesser-known mutual funds that are capable of generating big gains for you.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Sep 26, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS